• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    TAO Synergies Set to Join the Russell Microcap® Index as a Leading Public Gateway to Decentralized AI

    6/16/26 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $TAOX alert in real time by email

    NEW YORK, June 16, 2026 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) ("TAO Synergies" or the "Company"), the first pure play in capturing the opportunities emerging across decentralized artificial intelligence (DeAI) with its strategy centered on the Bittensor (TAO) ecosystem, a leading network powering decentralized AI, today announced its preliminary inclusion in the Russell Microcap® Index as part of the 2026 Russell Reconstitution.

    The Company's approach spans the full breadth of the Bittensor opportunity: owning TAO — where TAO Synergies is the largest publicly traded holder of TAO — as well as investing in Bittensor subnets, developing its own subnets, building decentralized AI applications, and pursuing additional opportunities across the DeAI landscape.

    The Russell Microcap® Index measures the performance of the microcap segment of the U.S. equity market and is widely used by investment managers and institutional investors for index funds and benchmarked investment strategies. Inclusion is expected to meaningfully increase TAO Synergies' visibility among institutional investors and the broader investment community, and to broaden the Company's exposure to index-oriented investment products.

    "Joining the Russell Microcap® Index is a significant milestone that reflects TAO Synergies' growth and rising profile in the public markets," said Executive Chairman Joshua Silverman. "As one of the world's largest holders of TAO and a builder within the Bittensor ecosystem, we offer investors a differentiated, transparent way to participate in decentralized AI — one of the most compelling frontiers in technology today. We believe Russell Microcap Index inclusion will expand awareness of our strategy and bring it to a wider audience of institutional and index-oriented investors."

    The Russell Reconstitution is final after the close of the U.S. equity markets on Friday, June 26, 2026. Equity markets will open with the newly reconstituted Russell U.S. Indexes on Monday, June 29, 2026. Inclusion in the Russell Microcap® Index remains subject to FTSE Russell's final determination.

    About TAO Synergies

    TAO Synergies Inc. (NASDAQ:TAOX) is the first pure-play public company dedicated to the intersection of cryptocurrency and artificial intelligence, focused on the opportunities emerging across decentralized AI and the Bittensor (TAO) ecosystem. The Company acquires and stakes TAO — ranking among the top 20 holders globally and as the largest publicly traded holder of TAO while investing in and developing Bittensor subnets, building decentralized AI applications, and pursuing further opportunities across the DeAI frontier. By providing transparent, regulated exposure to decentralized AI, TAO Synergies empowers investors to participate in the next era of technological disruption. For more information, visit www.taosynergies.com, taodaily.com, and @TAOSynergies on X.

    Forward-Looking Statements

    Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally can be identified by words such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "projects," "will," and similar expressions. Such forward-looking statements are subject to risks and uncertainties and other influences, many of which the Company has no control over. These forward-looking statements include, among other things, statements about: the expected benefits of the Company's inclusion in the Russell Microcap® Index, including increased institutional visibility and broader exposure to index-oriented investment products; our decentralized AI strategy and our activities within the Bittensor ecosystem, including the acquisition and staking of TAO, investment in and development of subnets, and development of decentralized AI applications; our new media platform, including the accuracy of Bittensor-related information provided thereon; the reputational impact of our new media platform; the potential value to shareholders; and other factors described from time to time in documents that we file with the Securities and Exchange Commission. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties, including, among other things, digital asset price volatility, regulatory changes affecting digital assets, and risks inherent in the Company's strategy. These and other factors are identified and described in more detail in the Company's filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company does not undertake to update these forward-looking statements.

    Investor Contact 

    800-811-5591

    ir@taosynergies.com

    Cision View original content:https://www.prnewswire.com/news-releases/tao-synergies-set-to-join-the-russell-microcap-index-as-a-leading-public-gateway-to-decentralized-ai-302801330.html

    SOURCE TAO Synergies Inc.

    Get the next $TAOX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TAOX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TAOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Executive Chairman Silverman Joshua

    4 - TAO Synergies Inc. (0001571934) (Issuer)

    5/19/26 6:45:59 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Bernstein Bruce

    4 - TAO Synergies Inc. (0001571934) (Issuer)

    5/19/26 6:45:11 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Singer William S.

    4 - TAO Synergies Inc. (0001571934) (Issuer)

    5/19/26 6:44:35 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TAOX
    SEC Filings

    View All

    Amendment: SEC Form 10-K/A filed by Tao Synergies Inc.

    10-K/A - TAO Synergies Inc. (0001571934) (Filer)

    6/5/26 4:18:22 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Tao Synergies Inc.

    10-Q - TAO Synergies Inc. (0001571934) (Filer)

    5/13/26 5:00:45 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Tao Synergies Inc.

    10-K - TAO Synergies Inc. (0001571934) (Filer)

    3/31/26 5:21:40 PM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TAOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TAO Synergies Set to Join the Russell Microcap® Index as a Leading Public Gateway to Decentralized AI

    NEW YORK, June 16, 2026 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) ("TAO Synergies" or the "Company"), the first pure play in capturing the opportunities emerging across decentralized artificial intelligence (DeAI) with its strategy centered on the Bittensor (TAO) ecosystem, a leading network powering decentralized AI, today announced its preliminary inclusion in the Russell Microcap® Index as part of the 2026 Russell Reconstitution. The Company's approach spans the full breadth of the Bittensor opportunity: owning TAO — where TAO Synergies is the largest publicly traded holder of TAO — as well as investing in Bittensor subnets, developing its own subnets, building decentralized AI app

    6/16/26 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation

    November 18 at 12:15 p.m. ET—Bittensor expert James Altucher and Yuma CRO Evan Malanga dive deep into TAO, decentralized AI, and network outlook as TAO halving approaches TAO Synergies is the largest publicly traded holder of Bittensor's native TAO token, first public company to invest in blockchain subnets NEW YORK, Nov. 18, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) ("TAO Synergies" or the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (DeAI), today announced that it will partner with Yuma to participate in a Yuma Asset Management Investor Spotlight, an X Livestream event today, Tuesday

    11/18/25 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds

    Seeks to optimize returns for shareholders while fostering evolution of Bittensor's decentralized machine intelligence marketplace NEW YORK, Nov. 4, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) ("TAO Synergies" or the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (DeAI), today announced an initial $750,000 investment in Yuma Asset Management's Bittensor Subnet Funds, enhancing the Company's exposure to subnets in the Bittensor ecosystem. These positions demonstrate TAO Synergies' commitment to decentralized AI, the Bittensor / TAO crypto token, and subnet tokens that will ultimately drive t

    11/4/25 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TAOX
    Financials

    Live finance-specific insights

    View All

    TAO Synergies Acquires $10 Million of Bittensor (TAO) to Become Largest Publicly Traded Pure Play TAO Holder

    29,899 TAO tokens purchased to date Stakes tokens in decentralized AI network for yield generation NEW YORK, July 17, 2025 /PRNewswire/ -- TAO Synergies Inc. (NASDAQ:TAOX) (the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (AI), today announced that as of July 17, 2025, it has acquired 29,899 TAO tokens for a total purchase price of $10.0 million, at an average price of approximately $334 per token. The purchases of TAO are in accordance with the Company's digital asset treasury strategy directed toward TAO, the native token for Bittensor, a decentralized AI network that incentivizes the development

    7/17/25 9:15:00 AM ET
    $TAOX
    Biotechnology: Pharmaceutical Preparations
    Health Care